Genmab A/S
GMAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001434265
No open-market purchases or sales by Genmab A/S insiders were filed in the last 90 days; 291 institutions reported holding it in 13F filings for Q2 2026, worth $2.81B in total; no superinvestor holds it.
Other share classesGNMSF
Q2 2024 vs. Q1 2024
How the institutions holding Genmab A/S changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 227 | 220 | −7 |
| Shares | 48.0M | 48.7M | +789.1K (+1.6%) |
| Value | $1.43B | $1.23B | −$206.9M (−14.4%) |
New holders (27)
Institutions that held Genmab A/S at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (34)
Institutions that held Genmab A/S at the end of Q1 2024 and filed for Q2 2024 without it.